The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-(2-Hexylhydrazine-1-carbonyl)benzyl)benzamide ID: ALA4740950
PubChem CID: 139558698
Max Phase: Preclinical
Molecular Formula: C21H27N3O2
Molecular Weight: 353.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCNNC(=O)c1ccc(CNC(=O)c2ccccc2)cc1
Standard InChI: InChI=1S/C21H27N3O2/c1-2-3-4-8-15-23-24-21(26)19-13-11-17(12-14-19)16-22-20(25)18-9-6-5-7-10-18/h5-7,9-14,23H,2-4,8,15-16H2,1H3,(H,22,25)(H,24,26)
Standard InChI Key: BXHBEDYMTAULCE-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
9.4248 -15.3230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7194 -14.9151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7186 -14.0979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0091 -13.6900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3004 -14.0993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3013 -14.9165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0108 -15.3244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4256 -16.1402 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1335 -14.9137 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8389 -15.3216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5475 -14.9123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2570 -15.3243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9616 -14.9150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9608 -14.0978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2554 -13.6899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5467 -14.0951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6695 -13.6885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6686 -12.8713 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.3790 -14.0964 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0876 -13.6871 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0868 -12.8699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7914 -12.4606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7947 -11.6434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4992 -11.2341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4984 -10.4169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2071 -10.0076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
2 7 2 0
1 8 2 0
1 9 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
17 18 2 0
19 20 1 0
17 19 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
20 21 1 0
14 17 1 0
9 10 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 353.47Molecular Weight (Monoisotopic): 353.2103AlogP: 3.43#Rotatable Bonds: 10Polar Surface Area: 70.23Molecular Species: NEUTRALHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.90CX LogP: 3.76CX LogD: 3.76Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.45Np Likeness Score: -0.89
References 1. McClure JJ,Zhang C,Inks ES,Peterson YK,Li J,Chou CJ. (2016) Development of Allosteric Hydrazide-Containing Class I Histone Deacetylase Inhibitors for Use in Acute Myeloid Leukemia., 59 (21): [PMID:27754681 ] [10.1021/acs.jmedchem.6b01385 ]